FOR HEMOPHILIA A
In the clinical study of 19 patients, 82% of bleeding episodes (n=306) were treated successfully with a single KOĀTE infusion.1*
In the clinical study, no evidence of inhibitor formation was observed in 34 previously treated patients over the course of 6 months treatment.2✝
The formation of inhibitors to KOĀTE may occur. Monitor all patients for the development of FVIII inhibitors by clinical observation and laboratory tests.1
References: 1. KOĀTE [prescribing information]. Fort Lee, NJ. Kedrion Biopharma Inc. 2018. 2. Powell JS, Bush M, Harrison J, et al. Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80°C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000;6:140-149.